1. Home/
  2. Compounds/
  3. alisertib:navitoclax (2:1 mol/mol)

alisertib:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2alisertib:navitoclax (2:1 mol/mol)
PharmacoGx alisertib:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to alisertib:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NRROS CTRPv2 pan-cancer AAC 0.22 7e-07
mRNA HNRNPA0 CTRPv2 pan-cancer AAC 0.22 2e-09
mRNA SMAD9 CTRPv2 pan-cancer AAC 0.22 8e-08
mRNA FBRSL1 CTRPv2 pan-cancer AAC 0.23 9e-10
mRNA ZNF184 CTRPv2 pan-cancer AAC 0.23 6e-09
mRNA MEX3A CTRPv2 pan-cancer AAC 0.23 6e-08
mRNA ILF3 CTRPv2 pan-cancer AAC 0.23 5e-09
mRNA DOT1L CTRPv2 pan-cancer AAC 0.23 1e-07
mRNA SOX11 CTRPv2 pan-cancer AAC 0.23 2e-07
mRNA HCFC1 CTRPv2 pan-cancer AAC 0.23 7e-09
Download CSV